Correlation Between Zura Bio and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Zura Bio and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Zura Bio and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Recursion Pharmaceuticals.
Diversification Opportunities for Zura Bio and Recursion Pharmaceuticals
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Zura and Recursion is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Zura Bio i.e., Zura Bio and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Zura Bio and Recursion Pharmaceuticals
Given the investment horizon of 90 days Zura Bio Limited is expected to under-perform the Recursion Pharmaceuticals. In addition to that, Zura Bio is 1.42 times more volatile than Recursion Pharmaceuticals. It trades about -0.26 of its total potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about -0.12 per unit of volatility. If you would invest 687.00 in Recursion Pharmaceuticals on August 28, 2024 and sell it today you would lose (87.00) from holding Recursion Pharmaceuticals or give up 12.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zura Bio Limited vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Zura Bio Limited |
| Recursion Pharmaceuticals |
Zura Bio and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zura Bio and Recursion Pharmaceuticals
The main advantage of trading using opposite Zura Bio and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Zura Bio vs. Eliem Therapeutics | Zura Bio vs. HCW Biologics | Zura Bio vs. Scpharmaceuticals | Zura Bio vs. Milestone Pharmaceuticals |
| Recursion Pharmaceuticals vs. Eliem Therapeutics | Recursion Pharmaceuticals vs. HCW Biologics | Recursion Pharmaceuticals vs. Scpharmaceuticals | Recursion Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |